Literature DB >> 9039402

The irritable bowel syndrome.

C Y Francis1, P J Whorwell.   

Abstract

Irritable bowel syndrome is a common disorder varying in severity from trivial to incapacitating. The pathophysiology and epidemiology are gradually being unravelled and it is now becoming apparent just how poor the quality of life of some of these patients can be. It is no longer acceptable practice to diagnose the condition and discharge the patient on a high fibre diet, particularly as the latter can often make the situation worse. Although hard to treat, worthwhile responses can be achieved by careful targeting of therapy to the many different facets of the disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039402      PMCID: PMC2431185          DOI: 10.1136/pgmj.73.855.1

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  35 in total

1.  The irritable bowel syndrome. Part I: clinical spectrum.

Authors:  J F Fielding
Journal:  Clin Gastroenterol       Date:  1977-09

2.  Irritable bowel syndrome: prevalence, prognosis and consequences.

Authors:  W G Thompson
Journal:  CMAJ       Date:  1986-01-15       Impact factor: 8.262

3.  Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome.

Authors:  R F Harvey; A E Read
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

4.  Irritable bowel syndrome in the gynecological clinic. Survey of 798 new referrals.

Authors:  A Prior; K Wilson; P J Whorwell; E B Faragher
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

5.  Cephalic phase of colonic pressure response to food.

Authors:  J Rogers; A H Raimundo; J J Misiewicz
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

6.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

7.  More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology.

Authors:  D G Maxton; J Morris; P J Whorwell
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

8.  A study of irritable bowel syndrome diagnosed by Manning criteria in an African population.

Authors:  I O Olubuyide; F Olawuyi; A A Fasanmade
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

9.  Gynaecological consultation in patients with the irritable bowel syndrome.

Authors:  A Prior; P J Whorwell
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

10.  Bladder smooth muscle dysfunction in patients with irritable bowel syndrome.

Authors:  P J Whorwell; E W Lupton; D Erduran; K Wilson
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

View more
  5 in total

1.  Innervation of enteric mast cells by primary spinal afferents in guinea pig and human small intestine.

Authors:  Guo-Du Wang; Xi-Yu Wang; Sumei Liu; Meihua Qu; Yun Xia; Bradley J Needleman; Dean J Mikami; Jackie D Wood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-21       Impact factor: 4.052

2.  Health status and management of chronic non-specific abdominal complaints in general practice.

Authors:  H A Janssen; J A Borghouts; J W Muris; J F Metsemakers; B W Koes; J A Knottnerus
Journal:  Br J Gen Pract       Date:  2000-05       Impact factor: 5.386

3.  Cystitis increases colorectal afferent sensitivity in the mouse.

Authors:  Pablo Rodolfo Brumovsky; Bin Feng; Linjing Xu; Carly Jane McCarthy; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

4.  Irritable bowel syndrome symptoms and health related quality of life in female veterans.

Authors:  D P Graham; L Savas; D White; R El-Serag; S Laday-Smith; G Tan; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2009-10-08       Impact factor: 8.171

5.  General practitioners believe that hypnotherapy could be a useful treatment for irritable bowel syndrome in primary care.

Authors:  Stephen Cox; Simon de Lusignan; Tom Chan
Journal:  BMC Fam Pract       Date:  2004-10-13       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.